Search
Search Results
##search.searchResults.foundPlural##
-
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1183PDF: 449HTML: 129 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2341PDF: 974HTML: 1630Fig 1: 167Tab I: 193Cover Letter: 185 -
Pseudo-differentiation syndrome
1297PDF: 635HTML: 10832Figure 1: peripheral blood showing myeloblasts with auer rods: 105Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 94Figure 3: CXR showing pulmonary infiltartes with consolidation: 121Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 93Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 108 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2027PDF: 966HTML: 4052Cover Letter: 206Figure 1: 210Figure 2: 216Table 1: 190 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4009PDF: 1540HTML: 847 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
679PDF: 795PDF Supp. Files: 69HTML: 171 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
1951PDF: 738HTML: 3102 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1494PDF: 566HTML: 170 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1346PDF: 790HTML: 8635Fig 3 Savini: 156Fig 2 Savini: 160Fig 1 Savini Chest TC: 169Author letter to referees: 170 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1182PDF: 557HTML: 2842ATRA induced Reactive Hemophagocytosis: A Case Report: 180 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4726PDF: 1718HTML: 2687Untitled: 193 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
936PDF: 519HTML: 711 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4699PDF: 1745HTML: 2102 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1175PDF: 937HTML: 192 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
3991PDF: 1116HTML: 1917Fig.1: 204Fig. 2: 102Table 1: 188Table2: 202Table 3: 182 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4023PDF: 1202HTML: 1944Table 1: 175 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1441PDF: 898HTML: 208 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1252PDF: 983HTML: 110 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
828PDF: 448HTML: 114Suppl. Files: 293 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
803PDF: 950Suppl. Files: 118HTML: 62







